Access the full text.
Sign up today, get DeepDyve free for 14 days.
R Sankaranarayanan, BM Nene, SS Shastri, K Jayant, R Muwonge, AM Budukh, S Hingmire, SG Malvi, R Thorat, A Kothari, R Chinoy, R Kelkar, S Kane, S Desai, VR Keskar, R Rajeshwarkar, N Panse, KA Dinshaw (2009)
HPV screening for cervical cancer in rural IndiaN Engl J Med, 360
D Saslow, D Solomon, HW Lawson (2012)
American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancerAm J Clin Pathol, 137
MJ Khan, PE Castle, AT Lorincz, S Wacholder, M Sherman, DR Scott, BB Rush, AG Glass, M Schiffman (2005)
The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus type 16 or 18 and the possible utility of type-specific HPV testing in clinical practiceJ Natl Cancer Inst, 97
M Lin, LY Yang, LJ Li, JR Wu, YP Peng, ZY Luo (2008)
Genital human papillomavirus screening by gene chip in Chinese women of Guangdong provinceAust N Z J Obstet Gynaecol, 48
K Kim, R Zang, SC Choi, SY Ryu, JW Kim (2009)
Current status of gynecological cancer in ChinaJ Gynecol Oncol, 20
Q Chen, LX Xie, ZR Qing, LJ Li, ZY Luo, M Lin, SM Zhang, WZ Chen, BZ Lin, QL Lin, H Li, WP Chen, PY Zheng, LZ Mao, CY Chen, C Yang, YZ Zhan, XZ Liu, JK Zheng, LY Yang (2012)
Epidemiologic characterization of human papillomavirus infection in rural Chaozhou, eastern Guangdong Province of ChinaPLoS One, 7
MH Forouzanfar, KJ Foreman, AM Delossantos, R Lozano, AD Lopez, CJ Murray, M Naghavi (2011)
Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysisLancet, 378
NW Bulkmans, J Berkhof, L Rozendaal, FJ Kemenade, AJ Boeke, S Bulk, FJ Voorhorst, RH Verheijen, K Groningen, ME Boon, W Ruitinga, M Ballegooijen, PJ Snijders, CJ Meijer (2007)
Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trialLancet, 370
MH Stoler, PE Castle, D Solomon, M Schiffman (2007)
The expanded use of HPV testing in gynecologic practice per ASCCP-guided management requires the use of well validated assaysAm J Clin Pathol, 127
J Laudadio (2013)
Human papillomavirus detection: testing methodologies and their clinical utility in cervical cancer screeningAdv Anat Pathol, 20
H Trottier, AN Burchell (2009)
Epidemiology of mucosal human papillomavirus infection and associated diseasesPublic Health Genomics, 12
G Ronco, P Giorgi-Rossi, F Carozzi, M Confortini, P Dalla Palma, A Mistro, B Ghiringhello, S Girlando, A Gillio-Tos, L Marco, C Naldoni, P Pierotti, R Rizzolo, P Schincaglia, M Zorzi, M Zappa, N Segnan, J Cuzick (2010)
Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trialLancet Oncol, 11
SK Kjær, K Frederiksen, C Munk, T Iftner (2010)
Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: role of persistenceJ Natl Cancer Inst, 102
AT Hesselink, J Berkhof, ML Salm, AP Splunter, TH Geelen, FJ Kemenade, MG Bleeker, DA Heideman (2014)
Clinical validation of the HPV-risk assay, a novel real-time PCR assay for detection of high-risk human papillomavirus DNA by targeting the E7 regionJ Clin Microbiol, 52
C Eklund, T Zhou, J Dillner (2010)
Global proficiency study of human papillomavirus genotypingJ Clin Microbiol, 48
A Anttila, L Kotaniemi-Talonen, M Leinonen, M Hakama, P Laurila, J Tarkkanen, N Malila, P Nieminen (2010)
Rate of cervical cancer, severe intraepithelial neoplasia, and adenocarcinoma in situ in primary HPV DNA screening with cytology triage: randomised study within organised screening programmeBMJ, 340
CJ Meijer, J Berkhof, PE Castle, AT Hesselink, EL Franco, G Ronco, M Arbyn, FX Bosch, J Cuzick, J Dillner, DA Heideman, PJ Snijders (2009)
Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and olderInt J Cancer, 124
M Arbyn, X Castellsagué, S Sanjosé, L Bruni, M Saraiya, F Bray, J Ferlay (2011)
Worldwide burden of cervical cancer in 2008Ann Oncol, 22
In the present study, we describe the laboratory workflow and the clinical validation of a novel multiplex real-time PCR-based HPV assay in China. The cross-sectional validation analysis showed that this assay worked well for detection of 14 HR-HPV types and identification of HPV 16 and 18 in a single sensitive assay that is suitable for both clinical usage and high-throughput cervical screening purposes. We predict that this accurate, high-throughput and low-cost HPV assay can greatly reduce the heavy economic burden of HPV detection in China.
Archives of Virology – Springer Journals
Published: Feb 1, 2016
Access the full text.
Sign up today, get DeepDyve free for 14 days.